Taro Horino
36PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (36)
Sort by Publication Date:
|May 15, 2025
Clinical significance of anti-lipoprotein lipase antibodies in Japanese patients with systemic lupus erythematosus.Taro Horino, Takeshi Kashio, Satoshi Inotani
|Apr 08, 2025
Urinary [TIMP-2]•[IGFBP7], TIMP-2, IGFBP7, NGAL, and L-FABP for the prediction of acute kidney injury following cardiovascular surgery in Japanese patients.Hideki Iwata, Taro Horino, Yuki Osakabe
|Feb 21, 2025
Efficacy of urinary [TIMP-2]⋅[IGFBP7], L-FABP, and NGAL levels for predicting community-acquired acute kidney injury in Japanese patients: a single-center, prospective cohort study.Satoshi Inotani, Takeshi Kashio, Yuki Osakabe
|Jan 24, 2025
Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy.Takeshi Kashio, Taro Horino, Kenichi Yagyu
|Nov 23, 2024
Effect of monoclonal gammopathy in the progression of acute kidney injury and chronic kidney disease: a retrospective observational study.Keita Mitani, Taro Horino, Yoshio Terada
|Sep 27, 2024
Effect of age, sex, and chronic kidney disease on urinary creatinine excretion in Japanese patients.Shigehiro Yasui, Taro Horino, Keita Mitani
Pageof 6
